文献速递慢性肾脏病肾小球疾病

非裔美国人肥胖与慢性肾脏病协同风险因素:杰克逊心脏研究

Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study.
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

本研究纳入2043名无基线肾病的非裔美国人,随访中位8年,评估肥胖指标与 incident CKD 的关联及与代谢和超滤因素的交互作用。结果显示基线BMI和腰围与CKD无关,但内脏脂肪体积与CKD非线性相关,且此效应仅限于饮食质量较低者;腰围与CKD的关联在高危APOL1基因型者中减弱。

要点

  • 内脏脂肪体积而非BMI或腰围,与非裔美国人CKD风险独立相关。
  • 饮食质量低者中内脏脂肪与CKD关联更强,提示代谢因素的关键作用。
  • APOL1高危基因型可能减弱腰围与CKD的关联,需在非裔人群中进一步研究。

核心结论

  • 内脏脂肪体积与 incident CKD 独立非线性相关,且效应限于饮食质量较低者。
  • 腰围与CKD的关联仅见于低危APOL1基因型者,高危基因型中无此关联。

研究设计与样本

  • 前瞻性队列研究,纳入2043名无基线肾病的非裔美国人,来自杰克逊心脏研究。
  • 肥胖指标包括BMI、性别标准化腰围和腹部CT测得的内脏脂肪体积。
  • 随访中位8年(范围6-11年),评估 incident CKD 及与代谢和超滤因素的交互作用。

主要发现

  • 基线BMI和腰围与 incident CKD 无显著关联。
  • 较高的内脏脂肪体积与 incident CKD 独立相关(P=0.008),呈非线性关系。
  • 内脏脂肪与CKD的关联仅限于饮食质量较低者(P=0.001;交互P=0.04)。
  • 腰围与CKD的关联在低危APOL1基因型者中显著(P=0.04),高危基因型者中不显著(交互P=0.02)。

临床怎么用

  • 评估非裔美国人CKD风险时,内脏脂肪体积可能比BMI或腰围更有价值。
  • 改善饮食质量可能减轻内脏脂肪相关的CKD风险。
  • 考虑APOL1基因型与肥胖的交互作用,尤其在高危基因型者中。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: African Americans are at high risk for chronic kidney disease (CKD). Obesity may increase the risk for CKD by exacerbating features of the metabolic syndrome and promoting glomerular hyperfiltration. Whether other factors also affecting these pathways may amplify or mitigate obesity-CKD associations has not been investigated. METHODS: We studied interactions between obesity and these candidate factors in 2043 African Americans without baseline kidney disease enrolled in the Jackson Heart Study. We quantified obesity as body mass index (BMI), sex-normalized waist circumference and visceral adipose volume measured by abdominal computed tomography at an interim study visit. Interactions were hypothesized with (i) metabolic risk factors (dietary quality and physical activity, both quantified by concordance with American Heart Association guidelines) and (ii) factors exacerbating or mitigating hyperfiltration (dietary protein intake, APOL1 risk status and use of renin-angiotensin system blocking medications). Using multivariable regression, we evaluated associations between obesity measures and incident CKD over the follow-up period, as well as interactions with metabolic and hyperfiltration factors. RESULTS: Assessed after a median of 8 years (range 6-11 years), baseline BMI and waist circumference were not associated with incident CKD. Higher visceral adipose volume was independently associated with incident CKD (P = 0.008) in a nonlinear fashion, but this effect was limited to those with lower dietary quality (P = 0.001; P-interaction = 0.04). In additional interaction models, higher waist circumference was associated with greater risk of incident CKD among those with the low-risk APOL1 genotype (P = 0.04) but not those with a high-risk genotype (P-interaction = 0.02). Other proposed factors did not modify obesity-CKD associations. Conclusions. Higher risks associated with metabolically active visceral adipose volume and interactions with dietary quality suggest that metabolic factors may be key determinants of obesity-associated CKD risk. Interactions between obesity and APOL1 genotype should be considered in studies of African Americans.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Olivo RE, Davenport CA, Diamantidis CJ, et al. Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study. Nephrol Dial Transplant. 2018. PMID: 28992354. doi:10.1093/ndt/gfx230

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。